BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, May 16, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 23, 2005
View Archived Issues
Private Deal Brings $31M To Memory For Research
Months after losing part of a partnership, Memory Pharmaceuticals Corp. extended its runway through the end of next year by raising about $31 million in gross proceeds through a private stock and warrant placement. (BioWorld Today)
Read More
Investors: Regulatory Rules Make Exit Paths Expensive
Read More
Snail's Cancer Role Expands From Metastasis To Relapse
Read More
CytRx Starting Phase II With Arimoclomol In ALS Patients
Read More
FDA Request Delays Decision On Avanir's Neurodex In PBA
Read More
Other News To Note
Read More